These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14598115)

  • 1. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(2):138-44. PubMed ID: 14598115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possibility of long-term cryopreservation of cultured dermal substitute.
    Kubo K; Kuroyanagi Y
    Artif Organs; 2005 Oct; 29(10):800-5. PubMed ID: 16185341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of cytokines released from fibroblasts in cultured dermal substitute.
    Kubo K; Kuroyanagi Y
    Artif Organs; 2005 Oct; 29(10):845-9. PubMed ID: 16185348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
    Sawa M; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
    Kubo K; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2003; 14(7):625-41. PubMed ID: 12903732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a matrix for cultured dermal substitute suitable for simultaneous transplantation with auto-skin graft: evaluation in animal test.
    Matsumoto Y; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2010; 21(1):83-94. PubMed ID: 20040155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
    Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(1):64-70. PubMed ID: 14598127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro.
    Kubo K; Kuroyanagi Y
    J Artif Organs; 2003; 6(4):267-72. PubMed ID: 14691669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.
    Kubo K; Kuroyanagi Y
    Artif Organs; 2004 Feb; 28(2):182-8. PubMed ID: 14961958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a wound dressing composed of hyaluronic acid and collagen sponge with epidermal growth factor.
    Kondo S; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2012; 23(5):629-43. PubMed ID: 21375805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: comparative culture study.
    Yu A; Niiyama H; Kondo S; Yamamoto A; Suzuki R; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2013; 24(8):1015-26. PubMed ID: 23647255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an artificial dermis composed of hyaluronic acid and collagen.
    Mineo A; Suzuki R; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2013; 24(6):726-40. PubMed ID: 23565912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute.
    Park SN; Kim JK; Suh H
    Biomaterials; 2004 Aug; 25(17):3689-98. PubMed ID: 15020144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications.
    Lin YC; Tan FJ; Marra KG; Jan SS; Liu DC
    Acta Biomater; 2009 Sep; 5(7):2591-600. PubMed ID: 19427824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
    Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
    Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of anti-adhesive spongy sheet composed of hyaluronic acid and collagen containing epidermal growth factor.
    Kuroyanagi M; Yamamoto A; Shimizu N; Toi A; Inomata T; Takeda A; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2014; 25(12):1253-65. PubMed ID: 24938709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound healing mediator production by human dermal fibroblasts grown within a collagen-GAG matrix for skin repair in humans.
    Froget S; Barthelemy E; Guillot F; Soler C; Coudert MC; Benbunan M; Dosquet C
    Eur Cytokine Netw; 2003; 14(1):60-4. PubMed ID: 12799215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor.
    Matsumoto Y; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2010; 21(6-7):715-26. PubMed ID: 20482980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor in diabetic mice.
    Kondo S; Niiyama H; Yu A; Kuroyanagi Y
    J Biomater Sci Polym Ed; 2012; 23(13):1729-40. PubMed ID: 21943516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.